Editorial Board Member - JPDD
Shi J. Liu
ProfessorDepartment of Pharmaceutical Sciences
University of Arkansas for Medical Sciences
United States
BIOGRAPHY:
Dr. Shi J. (Jesse) Liu have studied transmembrane ion transport in cultured adult ventricular myocytes for more than 10 years. With multi-disciplinary approaches, we continued on pathophysiological and pharmacological research of inflammatory cardiovascular disorders such as signal transduction pathways involved in proinflammatory cytokines in cardiac cells. Our work has focused primarily on mechanisms underlying cell survival and cell death associated with cardiocytoxity or declined cardiac function in chemotherapy for cancer patients and others. The overall goal is to develop new drugs that improve the survival of heart cells while eliminating cancer cells or in inflammatory conditions.
RESEARCH INTERESTS:
Dr. Jesse's research interests have extended to the field of drug discovery from natural products and the associated therapeutic target of cellular mechanisms.
Other Editorial Board Members - JPDD
SUNLIANG CUI
College of Pharmaceutical Sciences
Zhejiang University
China
BADER MUBARAK W. AL-JAEID
King Abdulaziz University
Saudi Arabia
GAETANO GIAMMONA
Pharmaceutical Technologies
University of Palermo
Italy
FRANCISCO FERNANDEZ CAMPOS
Department of Pharmaceutical Technology
University of Barcelona
Spain
Michael Zhuo Wang
Department of Pharmaceutical Chemistry
The University of Kansas
United States
SHAUKAT ALI
BASF Corporation
Pharma Solutions
United States
Michael P. Namaka
Faculty of Pharmacy and Medicine
University of Manitoba
Canada
Emmanuel Ho
Department of Immunology
University of Manitoba
Canada
Robert Nistico
Department of Pharmacy and Medicine
Sapienza University of Rome
Italy
James David Adams
Department of Pharmacology and Pharmaceutical Sciences
University of Southern California
United States